EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Clinical trials for EXTENSIVE-STAGE SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE-STAGE SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for EXTENSIVE-STAGE SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for aggressive lung cancer: drug duo takes on chemo in major trial
Disease control Not yet recruitingThis study tests a new drug combination (BL-B01D1 plus tislelizumab) against standard chemotherapy plus tislelizumab as the first treatment for people with extensive-stage small cell lung cancer. About 562 adults with this advanced cancer will take part. The goal is to see if the…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:39 UTC
-
New hope for tough lung cancer: combo therapy targets tumors after first treatment fails
Disease control Not yet recruitingThis study tests a combination of two drugs (sacituzumab tirumotecan and anlotinib) in 30 adults with extensive-stage small cell lung cancer that has worsened after initial treatment with immunotherapy and chemotherapy. The goal is to see if the combination can shrink tumors or s…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: China Medical University, China • Aim: Disease control
Last updated May 26, 2026 11:35 UTC
-
Engineered immune cells take aim at deadly lung cancer
Disease control Not yet recruitingThis early-phase study tests a treatment that uses a patient's own immune cells, modified to recognize and attack cancer cells that carry a protein called B7-H3. The study includes up to 40 adults with extensive-stage small cell lung cancer or extrapulmonary neuroendocrine cancer…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New combo aims to keep advanced lung cancer in check
Disease control Not yet recruitingThis study tests whether a combination of two drugs (lurbinectedin and durvalumab) can help keep extensive-stage small-cell lung cancer from growing after initial chemotherapy. About 50 adults whose cancer did not worsen after first treatment will receive this maintenance therapy…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Lung cancer study aims to improve care by watching Real-World treatments
Knowledge-focused Not yet recruitingThis study observes how patients with extensive-stage small cell lung cancer are treated in everyday hospital settings and how they respond. Researchers will collect data from medical records and follow participants for about 3 months at a time. The goal is to learn which treatme…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC